Indivior Pharmaceuticals (INDV) Asset Utilization Ratio (2024 - 2026)
Indivior Pharmaceuticals (INDV) recorded quarterly Asset Utilization Ratio of 1.08 in Q1 2026, up 13.62% quarter-over-quarter from 0.95 in Q4 2025, and up 23.72% on a YoY basis from 0.87 in Q1 2025.
Indivior Pharmaceuticals (INDV) Asset Utilization Ratio (2024 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Asset Utilization Ratio history runs 3 years deep, the most recent figure standing at 1.08 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio rose 23.72% year-over-year to 1.08; the TTM figure through Mar 2026 stood at 1.08 (up 23.72% YoY), while the FY2025 annual figure was 0.98, up 27.37% from the prior year.
- Asset Utilization Ratio was 1.08 for Q1 2026 at Indivior Pharmaceuticals, up from 0.95 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 1.08 in Q1 2026 to a low of 0.77 in Q4 2024.
- Historically, Asset Utilization Ratio has averaged 0.89 across 3 years, with a median of 0.85 in 2025.
- The sharpest annual moves came in 2025 and 2026: Asset Utilization Ratio rose 22.94% in 2025, then increased 23.72% in 2026.
- A 3-year view of Asset Utilization Ratio shows it stood at 0.77 in 2024, then grew by 22.94% to 0.95 in 2025, then increased by 13.62% to 1.08 in 2026.
- The last three Asset Utilization Ratio figures came in at 1.08 (Q1 2026), 0.95 (Q4 2025), and 0.82 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 0.43 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 0.62 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 0.43 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.48 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 0.65 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.37 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 0.36 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 0.68 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.07 |
| 10 | Indivior Pharmaceuticals | - | - | 277.00 Mn | 1.08 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.08 |
| Dec 31, 2025 | 0.95 |
| Sep 30, 2025 | 0.82 |
| Jun 30, 2025 | 0.83 |
| Mar 31, 2025 | 0.87 |
| Dec 31, 2024 | 0.77 |